Skip to main content
NewslettersWatchlist

Catalent Inc(CTLT-N)
NYSE

Today's Change
Delayed Last Update
Day Low63.44
Day High63.50
Open:63.49
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Select a category then submit the form to load news
Baystreet
Markets Look Ahead to Short Week
Motley Fool
Prediction: Up 74% So Far This Year, This Weight Loss Stock Is About to Crater
Barchart
1 Huge New Reason This Diet Drug Stock is a Must-Own
Healthcare - syringe-and-red-cross_MyWX9LvO-SBI-300194435
OTOS Inc.
Higher For Longer: These Sectors And Stocks Could Thrive Under Higher Interest Rates
Real Estate, Housing - shutterstock_2259342275
Motley Fool
Soaring Eli Lilly Stock Could Climb Another 24% According to a Wall Street Analyst. Is the Stock a Buy Now?
Motley Fool
Best Obesity Drug Stock: Eli Lilly, Novo Nordisk, or Viking Therapeutics?
Motley Fool
Did Novo Nordisk Just Get a Jump on Eli Lilly?
Motley Fool
Prediction: Eli Lilly and Novo Nordisk Stock Could Just be Getting Started. Here's Why
Barchart
Europe's Most Valuable Stock Is a Must-Own Near 52-Week Highs
Healthcare - syringe-against-blue-background_Gk-fpDwO-SBI-300198680
Motley Fool
Novo Nordisk Is Scaling a Barrier to Growth. Should You Buy Its Stock Now?
Motley Fool
Novo Nordisk Just Gave Investors $16.5 Billion More Reasons to Get Excited
Barchart
Novo Nordisk vs. Eli Lilly: Which Mega-Cap Healthcare Stock is a Better Buy for 2024?
Healthcare - syringe-and-red-cross_MyWX9LvO-SBI-300194435
Barchart
Broader Market Ends Higher as T-note Yields Decline
Wall Street - New York Stock Exchange NYSE
Motley Fool
Why Catalent Stock Soared Today
Motley Fool
Why Novo Nordisk Stock Crushed the Market on Monday
Barchart
Stocks Finish Lower as Rate Cut Hopes Recede on Hawkish Fed
Wall Street - NY Stock Exchange -mHdATQY9fIU-unsplash
Barchart
Stocks Fall as Bond Yields Jump on Hawkish Fed Comments and Strong ISM Services Report
Wall Street - shutterstock_1321462397
Barchart
Markets Today: Stocks Slip on Hawkish Fed Comments
Wall Street - shutterstock_156562427
MarketBeat
Flee to Healthcare Stocks if Recession Rears its Head?
Motley Fool
Why Catalent Stock Zoomed 12% Higher This Week
Barchart
Stocks Move Higher Before the Open as Investors Await Key U.S. GDP Data, Salesforce Earnings on Tap
Wall Street - shutterstock_2269106477
Motley Fool
Why Catalent Stock Surged Nearly 5% Higher Today
Barchart
Stocks Rally on Improved Prospects for a Pause in Fed Rate Hikes
Wall Street - Fearless girl on wall street-STJJ6OR3F1c-unsplash
Barchart
Stocks Jump as Weak U.S Economic News Bolsters the Outlook for a Fed Pause
Wall Street - shutterstock_181756637
Motley Fool
Why Novo Nordisk Stock Was Racing Higher on Wednesday
MarketBeat
Rising Dividend Make Zoetis a Doggone Winner
Barchart
Broader Market Falls on Disappointing Tech Earnings from Tesla and Netflix
Charts, tickers, traders - shutterstock_567496438
Barchart
Slump in Netflix and Tesla Weighs on Tech Stocks
Wall Street - shutterstock_1321462397
Barchart
Markets Today: Stocks Fall on Disappointing Earnings from Netflix and Tesla
Wall Street - shutterstock_156562427
Motley Fool
Why Catalent Stock Flopped Today
Barchart
Stocks Pressured by Hawkish Fed But Close Mostly Higher
Wall Street - shutterstock_2269106477
Barchart
Stocks Move Lower After Fed Meeting
Wall Street - shutterstock_1321462394

Profile

Catalent, Inc. is a renowned global provider of advanced delivery technologies as well as development and manufacturing solutions for drugs (protein, cell, and gene therapy biologics) and consumer health products.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2025.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2025 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.